CVC seeks investors to support Recordati acquisition deal
CVC Capital Partners is looking to gather investors to help finance its proposed acquisition of the Italian pharmaceutical company Recordati, valued at approximately <strong>€10.9 billion</strong> (around <strong>$12.7 billion</strong>). This move aims to enhance the company's competitive edge in the global pharmaceutical market.